Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neuroscience and Biobehavioral Reviews

• Publication date

  1994-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0149-7634(94)90049-3PMID 7984354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain

  2008cited by this paper
• Like diazepam, CL 218,872, a selective ligand for the benzodiazepine ω1 receptor subtype, impairs place learning in the Morris water maze

  2005cited by this paper
• Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia

  2005cited by this paper
• Discriminative stimulus properties of a new anxiolytic, DN-2327, in rats

  2005cited by this paper
• Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic

  2005cited by this paper
• Comparison of the daytime sleep and performance effects of zolpidem versus triazolam

  2005cited by this paper
• Effect of zolpidem on sleep in insomniac patients

  2004cited by this paper
• Memory and performance effects of single and 3-week administration of diazepam

  2004cited by this paper
• Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam

  2004cited by this paper
• Effects of chlordiazepoxide on passive avoidance responses in rats

  2004cited by this paper
• Increase of “antianxiety” activity and tolerance of behavioral depression during chronic administration of oxazepam

  2004cited by this paper
• Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR)

  2004cited by this paper
• Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls

  2004cited by this paper
• ZK 91296, a partial agonist at benzodiazepine receptors

  2004cited by this paper
• A simple and reliable conflict procedure for testing anti-anxiety agents

  2004cited by this paper
• The sedative effects of CL 218,872, like those of chlordiazepoxide, are reversed by benzodiazepine antagonists

  2004cited by this paper
• The comparative effects of benzodiazepines, progabide and PK 9084 on acquisition of passive avoidance in mice

  2004cited by this paper
• Long-lasting single-dose tolerance to neurologic deficits induced by diazepam

  2004cited by this paper
• Midazolam cue in rats: Generalization tests with anxiolytic and other drugs

  2004cited by this paper
• Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice

  2004cited by this paper
• Chronic use of benzodiazepines and psychomotor and cognitive test performance

  2004cited by this paper
• Anxiolytic drugs and the acquisition of conditioned fear in mice

  2004cited by this paper
• A comparison between chlordiazepoxide and CL 218,872—a synthetic nonbenzodiazepine ligand for benzodiazepine receptors on spontaneous locomotor activity in rats

  2004cited by this paper
• Identification:and immunohistochemical mapping of GABAA receptor subtypes containing the 6-subunit in rat brain

  2001cited by this paper
• Benzodiazepine receptor inverse agonists

  1995cited by this paper
• Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies

  1994cited by this paper
• Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps

  1994cited by this paper
• Comparison of the Effects of Zolpidem and Triazolam on Memory Functions, Psychomotor Performances, and Postural Sway in Healthy Subjects

  1993cited by this paper
• GABAA receptor populations with novel subunit combinations and drug binding profiles identified in brain by alpha 5- and delta-subunit-specific immunopurification.

  1993cited by this paper
• The rapidly expanding range of neuronal benzodiazepine receptor ligands.

  1993cited by this paper
• Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.

  1993cited by this paper
• Failure of flumazenil to precipitate a withdrawal syndrome in cats chronically treated with the new anxioselective p‐carboline derivative abecarnil

  1993cited by this paper
• Triazolam is more efficacious than diazepam in a broad spectrum of recombinant GABAA receptors.

  1993cited by this paper
• Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.

  1993cited by this paper
• Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.

  1993cited by this paper
• Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence.

  1993cited by this paper
• Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.

  1993cited by this paper
• Benzodiazepines, amnesia and sedation: Theoretical and clinical issues and controversies

  1992cited by this paper
• Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.

  1992cited by this paper
• Region-specific expression of GABAA receptor α3 and α4 subunits mRNAs in the rat brain

  1992cited by this paper
• GABAA receptor subunit messenger RNAs show differential expression during cortical development in the rat brain.

  1992cited by this paper
• Behavioral pharmacology of abecarnil in baboons: self‐injection, drug discrimination and physical dependence

  1992cited by this paper
• Mapping of GABAA receptor α5 and α6 subunit-like immunoreactivity in rat brain

  1992cited by this paper
• The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.

  1992cited by this paper
• Region-specific expression of GABAA receptor alpha 3 and alpha 4 subunits mRNAs in the rat brain.

  1992cited by this paper
• Mapping of GABAA receptor alpha 5 and alpha 6 subunit-like immunoreactivity in rat brain.

  1992cited by this paper
• Bi-directional changes in the levels of messenger RNAs encoding γ-aminobutyric acidA receptor α subunits after flurazepam treatment

  1992cited by this paper
• Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.

  1992cited by this paper
• Alpidem and Lorazepam in the Treatment of Patients with Anxiety Disorders: Comparison of Physiological and Psychological Effects

  1992cited by this paper
• Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors.

  1992cited by this paper
• Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.

  1992cited by this paper
• Bi-directional changes in the levels of messenger RNAs encoding gamma-aminobutyric acidA receptor alpha subunits after flurazepam treatment.

  1992cited by this paper
• Benzodiazepine receptor binding of benzodiazepine hypnotics: receptor and ligand specificity.

  1992cited by this paper
• Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS

  1992cited by this paper
• The third gamma subunit of the gamma-aminobutyric acid type A receptor family.

  1992cited by this paper
• Differential and transient expression of GABAA receptor alpha-subunit mRNAs in the developing rat CNS

  1992cited by this paper
• Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.

  1992cited by this paper
• Multiple benzodiazepine receptors: no reason for anxiety.

  1992cited by this paper
• GABAA receptor subunit mRNA levels are differentially influenced by chronic FG 7142 and diazepam exposure.

  1992cited by this paper
• Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.

  1992cited by this paper
• Benzodiazepines: use, abuse, and consequences.

  1992cited by this paper
• Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant β-carboline abecarnil

  1992cited by this paper
• Effect of a new anxiolytic, DN-2327, on learning and memory in rats.

  1992cited by this paper
• The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon

  1992cited by this paper
• The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum

  1992cited by this paper
• Alpidem and lorazepam in the treatment of patients with anxiety disorders: Comparison of efficacy and rebound

  1992cited by this paper
• The Lack of Tolerance to the Anxiolytic Effects of Benzodiazepines In The Geller/Seifter Conflict Test

  1991cited by this paper
• GABAA receptors display association of gamma 2-subunit with alpha 1- and beta 2/3-subunits.

  1991cited by this paper
• Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration

  1991cited by this paper
• Discriminative stimulus properties of the benzodiazepine receptor partial agonist β‐carbolines abecarnil and ZK 95962: a comparison with chlordiazepoxide

  1991cited by this paper
• The gamma 3-subunit of the GABAA-receptor confers sensitivity to benzodiazepine receptor ligands.

  1991cited by this paper
• GABAA receptor subtypes: from pharmacology to molecular biology

  1991cited by this paper
• Identification and immunohistochemical mapping of GABAA receptor subtypes containing the delta-subunit in rat brain.

  1991cited by this paper
• Immunohistochemical localization of the α1, α2 and α3 subunit of the GABAA receptor in the rat brain

  1991cited by this paper
• Generation of Two Forms of the γ‐Aminobutyric AcidA Receptor γ‐2‐Subunit in Mice by Alternative Splicing

  1991cited by this paper
• Bidirectional efficacy at benzodiazepine receptors of a series of imidazopyrimidines illustrated in drug discrimination studies

  1991cited by this paper
• The γ3‐subunit of the GABAA‐receptor confers sensitivity to benzodiazepine receptor ligands

  1991cited by this paper
• Distribution of GABAA-receptor a1 subunit gene expression in the rat forebrain

  1991cited by this paper
• [Interaction of the hypnotic lormetazepam with central benzodiazepine receptor subtypes omega 1, omega 2 and omega 3].

  1991cited by this paper
• Animal Models of Anxiety and the Screening and Development of Novel Anxiolytic Drugs

  1991cited by this paper
• Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity.

  1991cited by this paper
• Tolerance to anticonvulsant effects of the partial benzodiazepine receptor agonist abecarnil in kindled rats involves learning.

  1991cited by this paper
• Chronic benzodiazepine administration

  1991cited by this paper
• Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.

  1991cited by this paper
• The discriminative stimulus effects of diazepam in rats at two training doses.

  1991cited by this paper
• Differential tolerance to the antipentylenetetrazol activity of benzodiazepines in flurazepam-treated rats.

  1991cited by this paper
• Subjective and discriminative effects of drugs.

  1991cited by this paper
• Immunohistochemical localization of the alpha 1, alpha 2 and alpha 3 subunit of the GABAA receptor in the rat brain.

  1991cited by this paper
• Historical context of state dependent learning and discriminative drug effects.

  1991cited by this paper
• A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists.

  1991cited by this paper
• Distribution of GABAA-receptor alpha 1 subunit gene expression in the rat forebrain.

  1991cited by this paper
• The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.

  1991cited by this paper
• Dose response effects of zolpidem in normal geriatric subjects.

  1991cited by this paper
• Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site.

  1990cited by this paper
• Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.

  1990cited by this paper
• Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.

  1990cited by this paper
• Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology.

  1990cited by this paper
• Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.

  1990cited by this paper
• Selectivity for Omega-Receptor Subtypes as a Strategy for the Development of Anxiolytic Drugs

  1990cited by this paper
• Drug discrimination and drug stimulus generalization with anxiolytics

  1990cited by this paper

• Comparative potentiating effects of remimazolam, propofol and sevoflurane on rocuronium-induced neuromuscular block: a randomized controlled trial

  2025cites this paper
• Association Between Melatonin Receptor Agonists and Cardiac Arrhythmia; Disproportionality Analysis Studies Using Pharmacovigilance Databases

  2025cites this paper
• Preferential Synaptic Type of GABA-A Receptor Ligands Enhancing Neuronal Survival and Facilitating Functional Recovery After Ischemic Stroke.

  2024cites this paper
• Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry

  2023cites this paper
• Use of benzodiazepine and Z‐drugs and mortality in older adults after myocardial infarction

  2022cites this paper
• Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study

  2021cites this paper
• Effect of remimazolam on intraoperative neuromonitoring during thyroid surgery: a case series

  2021cites this paper
• Effects of N6‐(4‐hydroxybenzyl) adenine riboside in stress‐induced insomnia in rodents

  2020cites this paper
• Neurophysiology and Treatment of Disorders of Consciousness Induced by Traumatic Brain Injury: Orexin Signaling as a Potential Therapeutic Target.

  2019cites this paper
• Evaluation of morphine‐like effects of the mixed mu/delta agonist morphine‐6‐O‐sulfate in rats: Drug discrimination and physical dependence

  2018cites this paper
• Role of allopregnanolone biosynthesis in acute stress‐induced anxiety‐like behaviors in mice

  2017cites this paper
• Involvement of ATP-sensitive potassium channels and the opioid system in the anticonvulsive effect of zolpidem in mice.

  2016cites this paper
• Synthesis and pharmacological evaluation of functionalized isoindolinones on GABA-activated chloride currents in rat cerebellum granule cells in culture.

  2016cites this paper
• Functional Characterization of the 1,5-Benzodiazepine Clobazam and Its Major Active Metabolite N-Desmethylclobazam at Human GABAA Receptors Expressed in Xenopus laevis Oocytes

  2015cites this paper
• Problèmes posés par la consommation des benzodiazépines chez les personnes âgées : focus sur la mémoire

  2015cites this paper
• The effect of non-benzodiazepine hypnotics on sleep quality and severity in patients with OSA: a meta-analysis

  2014cites this paper
• Clobazam and Its Active Metabolite N-desmethylclobazam Display Significantly Greater Affinities for α2- versus α1-GABAA–Receptor Complexes

  2014cites this paper
• Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and “Anagrams” Generated Potent Antituberculosis Agents

  2014cites this paper
• Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress.

  2013cites this paper
• Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients

  2013cites this paper
• Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task

  2013cites this paper
• Pharmacotherapy for Disorders of Consciousness: Are ‘Awakening’ Drugs Really a Possibility?

  2013cites this paper
• Examining reelin expression and neural plasticity in animal models of depression

  2012cites this paper
• Anxioselective anxiolytics: on a quest for the Holy Grail.

  2012cites this paper
• Carryover effect on next‐day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial

  2012cites this paper
• Zolpidem tartrate.

  2012cites this paper
• Zolpidem for insomnia

  2012cites this paper
• Part I. Unified pharmacophore protein models of the benzodiazepine receptor subtypes. Part II. Subtype selective ligands for alpha5 Gaba(A) /BZ receptors

  2011cites this paper
• Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals

  2011cites this paper
• Zolpidem withdrawal delirium, seizure, and acute psychosis: Case reports and literature review

  2011cites this paper
• Structural and electronic effects of the C2’ substituent in 1,4–benzodiazepines

  2011cites this paper
• Zolpidem impairs non-associative memory in mice Zolpidem prejudica a memória não associativa em camundongos

  2011cites this paper
• Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.

  2010cites this paper
• Zolpidem increases bladder capacity and decreases urine excretion in rats

  2010cites this paper
• The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy.

  2010cites this paper
• Zolpidem is a potent anticonvulsant in adult and aged mice.

  2010cites this paper
• The role of purine and pyrimidine nucleosides in snake venoms.

  2009cites this paper
• Chapter 10 – References

  2009cites this paper
• Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders

  2009cites this paper
• Effects of the hypnotic drug zolpidem on cell proliferation and survival in the dentate gyrus of young and old rats.

  2009cites this paper
• Sleeping through the night: Are extended‐release formulations the answer?

  2008cites this paper
• Sedative and anticonvulsant effects of zolpidem in adult and aged mice

  2008cites this paper
• Sleep and geriatric psychopharmacology

  2008cites this paper
• Treatment Options for Insomnia-Pharmacodynamics of Zolpidem Extended-Release to Benefit Next-Day Performance

  2008cites this paper
• Dopaminergic and GABAergic Regulation of Alcohol-Motivated Behaviors: Novel Neuroanatomical Substrates

  2007cites this paper
• Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.

  2007cites this paper
• Pharmacokinetic and Pharmacodynamic Interactions Between Zolpidem and Caffeine

  2007cites this paper
• Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability

  2006cites this paper
• Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.

  2006cites this paper
• Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses.

  2006cites this paper
• Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

  2006cites this paper
• Dynamics and Kinetics of a Modified‐Release Formulation of Zolpidem: Comparison With Immediate‐Release Standard Zolpidem and Placebo

  2006cites this paper
• Zolpidem : Forensic aspects for the toxicologist and pathologist.

  2005cites this paper
• Contribution of GABAA Receptor Subtypes to the Anxiolytic-Like, Motor, and Discriminative Stimulus Effects of Benzodiazepines: Studies with the Functionally Selective Ligand SL651498 [6-Fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]

  2005cites this paper
• Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

  2005cites this paper
• The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.

  2005cites this paper
• Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and β-CCt

  2005cites this paper
• Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats

  2005influential citation
• The stimulus properties of LSD in C57BL/6 mice.

  2005cites this paper
• The antinociceptive effect of zolpidem and zopiclone in mice.

  2005cites this paper
• GABAA and Opioid Receptors of the Central Nucleus of the Amygdala Selectively Regulate Ethanol-Maintained Behaviors

  2004cites this paper
• The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents

  2004cites this paper
• Clinical Pharmacology, Clinical Efficacy, and Behavioral Toxicity of Alprazolam: A Review of the Literature

  2004cites this paper
• Research report Lysergic acid diethylamide and ()-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex

  2004cites this paper
• Differentiating the role of gamma-aminobutyric acid type A (GABAA) receptor subtypes.

  2004cites this paper
• Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

  2004cites this paper
• Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.

  2004cites this paper
• COX-2 Inhibitors

  2004cites this paper
• Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives

  2004cites this paper
• Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.

  2004cites this paper
• Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

  2003cites this paper
• Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.

  2003cites this paper
• Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance.

  2003cites this paper
• The Reinforcing Properties of Alcohol are Mediated by GABAA1 Receptors in the Ventral Pallidum

  2003cites this paper
• SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.

  2003cites this paper
• Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.

  2002cites this paper
• b-CCT, a selective BZ-v receptor antagonist, blocks

  2002cites this paper
• GABAA-benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice.

  2002cites this paper
• Effect of zaleplon on learning and memory in rats

  2002cites this paper
• Some contextual and historical determinants of the effects of chlordiazepoxide on punished responding of rats

  2002cites this paper
• Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.

  2002cites this paper
• Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/α1-preferring antagonist β-CCt in squirrel monkeys

  2002cites this paper
• The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.

  2002cites this paper
• [Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent].

  2002cites this paper
• Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone

  2002cites this paper
• Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite.

  2001cites this paper
• Tratamiento farmacológico del insomnio primario crónico: Análisis visual y espectral de los efectos del zolpidem sobre el electroencefalograma del sueño

  2001cites this paper
• Zolpidem, Triazolam, and Diazepam Decrease Distress Vocalizations in Mouse Pups: Differential Antagonism by Flumazenil and β-Carboline-3-carboxylate-t-butyl ester (β-CCt)

  2001cites this paper
• Pharmacodynamic profile of Zaleplon, a new non‐benzodiazepine hypnotic agent

  2001cites this paper
• Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).

  2001cites this paper
• Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening

  2001cites this paper
• The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry.

  2001cites this paper
• Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers

  2000influential citation
• Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors.

  2000cites this paper
• Effects of intraseptal zolpidem and chlordiazepoxide on spatial working memory and high-affinity choline uptake in the hippocampus.

  2000cites this paper
• Subtype-selective benzodiazepine receptor ligands

  2000cites this paper
• Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.

  2000cites this paper
• Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines.

  2000cites this paper
• Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors

  2000cites this paper
• β‐CCT, a selective BZ‐ω1 receptor antagonist, blocks the anti‐anxiety but not the amnesic action of chlordiazepoxide in mice

  2000cites this paper